|
Jul 30
|
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
|
|
Jul 30
|
Trade, Central Bank Outlooks Mix Asian Stock Markets
|
|
Jul 22
|
Domestic Policies, Tariffs Roil Asian Stock Markets
|
|
Jun 19
|
Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference
|